BPDCN treatment and management: CD123-targeting agents, CNS

BPDCN treatment and management: CD123-targeting agents, CNS involvement & approaching pediatric/AYA patients

Listen now

Description

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive hematologic malignancy originating from plasmacytoid dendritic cells, characterized by skin lesions...

More Episodes

See all »

CAR-T therapies and bispecific antibodies in the treatment of high-risk multiple myeloma: updates from iwHRMM 2024

This week’s podcast features discussions on the use of immunotherapy in the treatment of high-risk multiple myeloma (HRMM) from the...

Published 11/12/24

VJHemOnc Podcast

Published 11/12/24

The treatment landscape and challenges in rare diseases: BPDCN, CMML, MPN-AP/BP, and VEXAS

This podcast features a discussion from the 6th International Workshop on Acute Leukemias (iwAL) 2024, which took place in Phoenix,...

Published 11/06/24